Turn Therapeutics, Inc. (TTRX)
12.00
+0.61
(+5.36%)
USD |
NASDAQ |
Oct 09, 16:00
11.95
-0.05
(-0.42%)
After-Hours: 20:00
Turn Therapeutics EPS Diluted (Quarterly) : -0.1964 for June 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.1964 |
| March 31, 2026 | -0.0329 |
| December 31, 2025 | 0.0095 |
| Date | Value |
|---|---|
| September 30, 2025 | -0.068 |
| June 30, 2025 | -0.0902 |
| March 31, 2025 | -0.0112 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| ANI Pharmaceuticals, Inc. | 1.052 |
| Corcept Therapeutics, Inc. | 0.356 |
| Veru, Inc. | -0.3032 |
| Johnson & Johnson | 2.268 |
| Eli Lilly & Co. | 7.939 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -5.850M |
| Total Expenses (Quarterly) | 5.850M |
| Enterprise Value | 353.29M |
| Earnings Yield | -2.40% |
| Normalized Earnings Yield | -2.468 |